# Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy

> **NCT00243789** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cooperative International Neuromuscular Research Group** · enrollment: 64 (actual)

## Conditions studied

- Muscular Dystrophy, Duchenne

## Interventions

- **DRUG:** Pentoxifylline

## Key facts

- **NCT ID:** NCT00243789
- **Lead sponsor:** Cooperative International Neuromuscular Research Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-12
- **Final completion:** 2008-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2011-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243789, "Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00243789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*